newsfilter
← Latest News
GlobeNewswire·

Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q

WARREN, N.J., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN), today announced the filing of its quarterly report on Form 10-Q for the quarter ended September 30,